Equity

anonymous

Guest
Hey all - I’m a rep at a different company, however I have about 5k shares of esperion. Happy for you guys, its definitely a great company to be involved in despite the shakey past.

Curious, how much stock is offered to reps? 20k yearly seems to be pharma standard.

thanks for any info. Again, just curious.
 




Hey all - I’m a rep at a different company, however I have about 5k shares of esperion. Happy for you guys, its definitely a great company to be involved in despite the shakey past.

Curious, how much stock is offered to reps? 20k yearly seems to be pharma standard.

thanks for any info. Again, just curious.

Lol
I get the satire.
Well done.
 












No question that those blockbuster potential here. Once we gain broad formulary coverage later this year things will really start to takeoff. It’s going to be a whole new ball game in 25.
 








A lot of people are saying this is a $20 stock, seems quite plausible given the upside potential in the market. Most of the analysts have a strong buy, and more investors are seeking these outsized returns. Catalysts are soon.
 




A lot of people are saying this is a $20 stock, seems quite plausible given the upside potential in the market. Most of the analysts have a strong buy, and more investors are seeking these outsized returns. Catalysts are soon.

Okay Anthony this is the same crap your posting on yahoo finance. This isn't a 20.00 stock. It's inches from penny stock status. There's no strong buy. All institutions bailed out of this stock months and months ago. Stop deceiving people!
 




A lot of people are saying this is a $20 stock, seems quite plausible given the upside potential in the market. Most of the analysts have a strong buy, and more investors are seeking these outsized returns. Catalysts are soon.
How is $20 even something to brag about? Other similar start ups are at least in the 70s by now.